2. Menstruation Flashcards
Name phases of menstruation (2)
- FOLLICULAR/PROLIFERATIVE PHASE (Variable Duration)
- LUTEAL/SECRETORY PHASE (Fixed Duration - 14 days)
Describe EARLY follicular phase
- Initiating Events
- HPO Axis
- Hormones
- Feedback on HPO Axis
- Ovaries
- Endometrium
- Cervical Mucus
- Initiating Events: ⬇️ E and ⬇️ P (from end of previous cycle)
- HPO Axis:
- ⬆️ GnRH pulse frequency
- ⬆️ FSH
- ⬆️ LH pulse frequency
- Ovaries: ⬆️ FSH -> follicular growth in 3-30 follicles
- Endometrium: Menses from P withdrawal (from end of previous cycle)
Describe LATE follicular phase
- Initiating Events
- HPO Axis
- Hormones
- Feedback on HPO Axis
- Ovaries
- Endometrium
- Cervical Mucus
- Initiating Events: Growing follicles continue to secrete E
- Hormones: ⬆️E from follicles, especially from dominant follicle
- Ovaries:
- Dominant follicle persists, remainder undergo atresia
- Granulosa cells luteinize -> produce
- Endometrium: E builds up endometrium
Describe MID follicular phase
- Initiating Events
- HPO Axis
- Hormones
- Feedback on HPO Axis
- Ovaries
- Endometrium
- Cervical Mucus
- Initiating Events: ⬆️ FSH acts on ovarian granulosa cells
- HPO Axis: ⬆️E from follicles (ovary)
- Feedback on HPO Axis: Negative feedback E-> ⬇️FSH,⬇️LH
- Ovaries: follicular growth (by reducing atresia) -> ⬆️E
- Cervical Mucus: Clear, ⬆️ amount, Spinnbarkeit 8-10 cm, more stringy
Describe EARLY-MID luteal/secretory phase
- Initiating Events
- HPO Axis
- Hormones
- Feedback on HPO Axis
- Ovaries
- Endometrium
- Cervical Mucus
- Initiating Events: Switch back to negative feedback
- HPO Axis: ⬇️LH
- Hormones: ⬆️P from corpus luteum
- Feedback on HPO Axis: Negative feedback P -> ⬇️FSH,⬇️LH
- Endometrium: P stabilizes endometrium
Describe OVULATION
- Initiating Events
- HPO Axis
- Hormones
- Feedback on HPO Axis
- Ovaries
- Endometrium
- Cervical Mucus
- Initiating Events: Sudden switch from negative to positive feedback (E and P now ⬆️FSH & LH)
- HPO Axis: ⬆️⬆️LH pulse amplitude (LH surge)
- Hormones: E peaks -> LH surge -> ovulation
- Feedback on HPO Axis: Positive feedback: E and P -> ⬆️FSH,⬆️LH
- Ovaries: ~36 h after LH surge, dominant follicle releases oocyte; corpus luteum (remnant of dominant follicle) produces P
Describe LATE luteal/secretory phase
- Initiating Events
- HPO Axis
- Hormones
- Feedback on HPO Axis
- Ovaries
- Endometrium
- Cervical Mucus
- Initiating Events: No fertilized oocyte
- Hormones: ⬇️P secondary to degeneration of corpus luteum
- Ovaries: Cessation of P from corpus luteum
- Endometrium: Withdrawal of P -> menses
- Cervical Mucus: Opaque, scant amount, Spinnbarkeit 1-2 cm
Describe duration of:
- FOLLICULAR/PROLIFERATIVE PHASE
- LUTEAL/SECRETORY PHASE
- FOLLICULAR/PROLIFERATIVE PHASE: Variable Duration
- LUTEAL/SECRETORY PHASE: Fixed Duration - 14 days
What is the average age: menarche
10-15 yr
At what age does menstruation start on average?
12.2 yr
Average menstruation cycle length? (1)
- Entire cycle 28 ± 7 d with bleeding for 1-6 d
What’s the average blood loss per cycle? (1)
25-80 mL
Desribe: Estrogen (3)
- the main hormone in the follicular/proliferative phase and is stimulated by FSH.
- As the level increases it acts negatively on FSH.
- The majority of estrogen is secreted by the dominant follicle
Describe effects of estrogen (3)
- On the follicles in the ovaries: Reduces atresia
- On the endometrium: Proliferation of glandular and stromal tissue
- On all target tissues: Decreases E receptors
Describe: Progesterone (3)
- the main hormone in the luteal/secretory phase
- and is stimulated by LH.
- Increased progesterone acts negatively on LH and is secreted by the corpus luteum (remnant of dominant follicle)
Name: Progesterone effects (5)
- On the endometrium
- Cessation of mitoses (stops building endometrium up)
- “Organization” of glands (initiates secretions from glands)
- Inhibits macrophages, interleukin-8, and enzymes from degrading endometrium
- On all target tissues
- Decrease E receptors (the “anti-estrogen” effect)
- Decrease P receptors
Define: Adrenarche (2)
- increased secretion of adrenal androgens
- usually precedes gonadarche by 2 yr
Define: Gonadarche (2)
- increased secretion of gonadal sex steroids
- ~age 8 yr
Define: Thelarche (1)
- breast development
Define: Pubarche (1)
- pubic and axillary hair development
Define: Menarche (2)
- onset of menses
- usually following peak height velocity and/or 2 yr following breast budding
Name: Stages of Puberty (4)
“Boobs, Pubes, Grow, Flow”
Thelarche, Pubarche, Growth spurt, Menarche
Describe Tanner Stages: Thelarche (5)
- None
- Breast bud
- Further enlargement of areolae and breasts with no separation of contours
- 2º mound of areolae and papilla
- Areolae recessed to general contour of breast – adult
Describe Tanner Stages: Pubarche (5)
- None
- Downy hair along labia only
- Darker/coarse hair extends over pubis
- Adult-type hair with no thigh involvement
- Adult hair in distribution and type; extends over thighs. Not all patients achieve Tanner Stage 5.
Define: Premenstrual Syndrome (3)
- Physiological and emotional disturbances that occur 1-2 wk prior to menses and last until a few days after onset of menses
- common symptoms include depression, irritability, tearfulness, and mood swings
- synonyms: “ovarian cycle syndrome,” “menstrual molimina” (moodiness)
Describe etiologies: Premenstrual Syndrome (3)
- multifactorial: not completely understood; genetics likely play a role
- CNS-mediated neurotransmitter (serotonin, dopamine, GABA) interactions with sex steroids (P, E, and T)
- serotonergic dysregulation – currently most plausible theory
Name: Diagnostic Criteria for Premenstrual Syndrome
- at least one affective and one somatic symptom during the 5 d before menses in each of the three prior menstrual cycles
- affective: depression, angry outbursts, irritability, anxiety, confusion, social withdrawal
- somatic: breast tenderness or swelling, abdominal bloating, headache, swelling of extremities, joint or muscle pain, or weight gain
- symptoms relieved within 4 d of onset of menses and do not recur until at least day 13 of cycle
- symptoms present in the absence of any pharmacologic therapy, hormone ingestion, drug or alcohol use
- symptoms occur reproducibly during 2 cycles of prospective recording
- patient suffers from identifiable dysfunction in social or occupational performance
Describe FIRST LINE Premenstrual Syndrome Treatment (3)
- Exercise, cognitive behavioural therapy, vitamin B6 “
- combined hormonal contraception
- Continuous or luteal phase (day 15-28) low dose SSRIs (e.g. citalopram/escitalopram 10 mg)
Describe SECOND LINE Premenstrual Syndrome Treatment (2)
- Estradiol patches (100 micrograms) + micronised progesterone (100 mg or 200 mg [day 17-28], orally or vaginally) or LNG-IUS 52 mg
- Higher dose SSRIs continuously or luteal phase (e.g. citalopram/escitalopram 20-40 mg)
Describe THIRD LINE Premenstrual Syndrome Treatment (1)
GnRH analogues + add-back HRT
Describe FOURTH LINE Premenstrual Syndrome Treatment (1)
Surgical treatment ± HRT
Describe clinical features: Premenstrual Dysphoric Disorder (2)
- irritability, depressed mood
- breast pain and bloating
Name: Diagnostic Criteria for Premenstrual Dysphoric Disorder (4)
- at least 5 of the following 11 symptoms during most menstrual cycles of the last year (with at least 1 of the first 4)
- depressed mood or hopelessness
- anxiety or tension
- affective instability
- anger or irritability
- decreased interest in activities
- difficulty concentrating
- lethargy
- change in appetite
- hypersomnia or insomnia
- feeling overwhelmed
- physical symptoms: breast tenderness/swelling, headaches, joint/muscle pain, bloating, or weight gain
- symptoms cause significant distress and/or interfere with social or occupational functioning
- symptoms must be present during the week prior to menses and resolve within a few days after onset of menses
- may be superimposed on other psychiatric disorders, provided it is not merely an exacerbation of another disorder